Phil Newman: Longevity Biotechnology Investing

Join Phil Newman, CEO & Founder of Longevity.Technology, a digital investment platform for international investors and longevity start-ups, as he sits down at the LBA roundtable with Nir Barzilai for a presentation on Longevity Biotechnology Investing.

Explore key moments in the video:

4:22 | 2024: A look at where longevity stands today in mainstream media, influencer circles, and big Pharma.
5:12 | Market theory: the hype cycle, and where is longevity
6:00 | What is longevity anyway?
6:35 | The 25 longevity domains.
6:50 | Contrasting Longevity Now with Longevity Next.
7:09 | Total financing for longevity-related supplements and longevity clinics from 2018-2023.
9:30 | Defining Longevity: 3 Targets, 4 Pillars
13:15 | Exploring the 13 longevity domains specifically related to longevity biotech.
15:41 | QR code for the presentation slides.
15:52 | The cost of aging-related diseases in the US and the drivers behind aging.
20:10 | Discovering who contributes to longevity biotech data.
21:51 | Assessing the overall progress of longevity biotech domains.
22:56 | Unveiling the financing trends for longevity biotech over the last decade and highlighting the top domains.

Don't miss this in-depth journey into the world of Longevity Biotechnology Investing! 🚀 #LongevityInvesting #BiotechInvesting #TechTalk #LBARoundtable